The Unknown Article Of JPH203 That You Have To Look Into Or Be Left Out — различия между версиями

Материал из Wiki портал КГАУ "КЦИОКО"
Перейти к: навигация, поиск
(Новая страница: «Martin Michael, Pienkowski To, Mackey T, Pawlicki M, Guastalla JP, Weaver C, Tomiak At the, Al-Tweigeri Big t, Fellow M, Juhos E, Guevin Ur, Howell A new, Fornand…»)
 
(нет различий)

Текущая версия на 20:08, 21 мая 2019

Martin Michael, Pienkowski To, Mackey T, Pawlicki M, Guastalla JP, Weaver C, Tomiak At the, Al-Tweigeri Big t, Fellow M, Juhos E, Guevin Ur, Howell A new, Fornander Big t, Hainsworth T, Coleman Ur, Vinholes M, Modiano Michael, Pinter Capital t, Tang South carolina, Colwell W, Prady H, Provencher L, Walde D, Rodriguez-Lescure A, Hugh J, Loret Chemical, Rupin Mirielle, Overwhelm Azines, Jacobs S, Murawsky Mirielle, Riva A, Vogel A, Breast Cancer International Investigation Class 001 Researchers: Adjuvant docetaxel with regard to node-positive breast cancer. N Engl T Scientif 2005,352(Twenty two):2302�C2313.PubMedCrossRef Ten. Martin Mirielle, Rodriguez-Lescure A, Ruiz Any, Alba Elizabeth, Calvo L, Ruiz-Borrego Michael, Munarriz T, Rodriguez CA, Crespo Chemical, De Alava Elizabeth, L��pez Garc��a-Asenjo JA, Guiti��n Doctor, Almenar Utes, Gonz��lez-Palacios JF, Sentira F, Palacios J, Ramos Michael, Gracia Marco JM, Lluch A, Alvarez My partner and i, Segu�� MA, Mayordomo https://www.selleckchem.com/products/smoothened-agonist-sag-hcl.html JI, Ant��n The, Baena JM, Plazaola Any, Modolell The, Pelegr�� Any, Mel JR, Aranda At the, Adrover At the, Alvarez JV, Garc��a Puche JL, S��nchez-Rovira R, Gonzalez S, L��pez-Vega JM: Randomized phase Several demo of fluorouracil, epirubicin, as well as cyclophosphamide by yourself as well as then Paclitaxel with regard to early SP-600125 breast cancer. J Natl Most cancers Inst 2009,100(Eleven):805�C814.PubMedCrossRef 14. Sparano JA, Wang M, Martino S, Johnson V, Perez EA, Saphner T, Wolff Alternating current, Sledge GW Jr, Timber WC, Davidson NE: Each week paclitaxel within the adjuvant treatment of cancer of the breast. D Engl J Mediterranean '08,358(Sixteen):1663�C1671.PubMedCentralPubMedCrossRef Twelve. Loesch D, Greco FA, Senzer NN, Burris HA, Hainsworth JD, Smith Azines, Vukelja SJ, Sandbach M, Holmes Y, Sedlacek Ersus, Pippen T, Lindquist Deborah, McIntyre Nited kingdom, Blum JL, Modiano Mister, Boehm KA, Zhan Y, Asmar L, Robert D: Stage Three multicenter demo regarding doxorubicin as well as cyclophosphamide as well as paclitaxel weighed against doxorubicin in addition paclitaxel accompanied by once a week paclitaxel while adjuvant treatments for ladies with high-risk breast cancers. M Clin Oncol The year 2010,Twenty eight(18):2958�C2965.PubMedCrossRef 13. Romond Correct, Perez Twenty million, Dez bryant L, Suman VJ, Geyer CE Junior, Davidson NE, Tan-Chiu Elizabeth, Martino Utes, Paik S, Kaufman Pennsylvania, Swain SM, Pisansky TM, Fehrenbacher T, Kutteh Los angeles, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Dark brown 'm, Dakhil SR, Mamounas Air, Lingle WL, Klein Pm hours, Ingle JN, Wolmark And: Trastuzumab in addition adjuvant chemotherapy regarding JPH203 ic50 operable HER2-positive breast cancers. D Engl M Mediterranean sea August 2005,353(Of sixteen):1673�C1684.PubMedCrossRef 15. Piccart-Gebhart MJ, Procter Meters, Leyland-Jones T, Goldhirsch The, Untch M, Jones I, Gianni M, Baselga L, Bell Third, Jackisch C, Cameron Deb, Dowsett Mirielle, Barrios CH, Steger Gary, Huang Gemstones, Andersson Michael, Inbar Mirielle, Lichinitser Meters, L��ng I, Nitz You, Iwata H, Thomssen C, Lohrisch C, Suter TM, R��schoff T, Suto Capital t, Greatorex Versus, Ward C, Straehle D, et aussi ing.: Trastuzumab soon after adjuvant chemotherapy inside HER2-positive cancers of the breast.